Essity Aktiebolag (publ) - Third Quarter Report 2020
JANUARY 1 - SEPTEMBER 30, 2020
(compared with the corresponding period a year ago)
- Target raised for adjusted return on capital employed to above 17% by 2025. The previous target of above 15% for adjusted return on capital employed has been achieved during the last 12 months.
- Net sales declined 4.7% to SEK 90,796m (95,289)
- Organic net sales declined 2.4%
- Sales were negatively impacted by the COVID-19 pandemic and related lockdowns
- In emerging markets, which accounted for 36% of net sales, organic net sales increased 1.2%
- Operating profit before amortization of acquisition-related intangible assets (EBITA) increased 27% to SEK 13,177m (10,387)
- Adjusted EBITA increased 19% to SEK 13,234m (11,098)
- Adjusted EBITA margin increased 3.0 percentage points to 14.6% (11.6)
- Adjusted return on capital employed increased 2.9 percentage points to 15.7% (12.8)
- Profit for the period increased 22% to SEK 8,718m (7,166)
- Earnings per share increased 17% to SEK 10.80 (9.25)
- Adjusted earnings per share increased 9% to SEK 11.50 (10.59)
- Cash flow from current operations decreased 10% to SEK 8,560m (9,529)
- The Board proposes a dividend of SEK 6.25 (5.75) per share
EARNINGS TREND
SEKm | 2009 | 1909 | % | 2020:3 | 2019:3 | % |
Net sales | 90,796 | 95,289 | -5 | 28,677 | 32,565 | -12 |
Adjusted operating profit before amortization of acquisition- | ||||||
related intangible assets (EBITA)1 | 13,234 | 11,098 | 19 | 4,119 | 4,176 | -1 |
Operating profit before amortization of acquisition-related | ||||||
intangible assets (EBITA) | 13,177 | 10,387 | 27 | 4,018 | 3,975 | 1 |
Amortization of acquisition-related intangible assets | -610 | -576 | -201 | -196 | ||
Adjusted operating profit1 | 12,624 | 10,522 | 20 | 3,918 | 3,980 | -2 |
Items affecting comparability | -57 | -711 | -101 | -201 | ||
Operating profit | 12,567 | 9,811 | 28 | 3,817 | 3,779 | 1 |
Financial items | -786 | -1,006 | -184 | -320 | ||
Profit before tax | 11,781 | 8,805 | 34 | 3,633 | 3,459 | 5 |
Adjusted profit before tax1 | 11,838 | 9,516 | 24 | 3,734 | 3,660 | 2 |
Income taxes | -3,063 | -1,639 | -1,033 | -723 | ||
Profit for the period | 8,718 | 7,166 | 22 | 2,600 | 2,736 | -5 |
Earnings per share, SEK | 10.80 | 9.25 | 3.22 | 3.53 | ||
Adjusted earnings per share, SEK2 | 11.50 | 10.59 | 3.55 | 3.99 |
1Excluding items affecting comparability; for amounts see page 12.
2Excluding items affecting comparability and amortization of acquisition-related intangible assets.
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 1 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
SUMMARY
Essity is raising its target for adjusted return on capital employed to above 17% by 2025. The previous target of above 15% for adjusted return on capital employed has been achieved during the last 12 months. The raised target will be achieved through the continued execution of Essity's existing strategy, an accelerated digital transformation and further streamlining of production, logistics and distribution. Other financial targets remain unchanged.
Essity's innovation-driven category and channel strategy with leading brands combined with comprehensive efficiency improvements have contributed during the past three years to good organic sales growth and a gradual increase in profitability. Structural profitability in Consumer Tissue has been raised for example as a consequence of a higher share of own brands, a focus on growth in segments with high margins, successful innovations and more efficient production. In Baby Care, work is continuing to improve profitability and during the year we have, for example, exited underperforming positions in North Africa and Russia. In Incontinence Products, Medical Solutions and Feminine Care the focus remains on growth. In Professional Hygiene, an increased awareness of the importance of hygiene and health is eventually expected to result in rising demand.
Essity's digital transformation will accelerate in the years ahead through a new digital platform. This will further strengthen the Group's customer and consumer offerings, generate significant cost savings and reduce the need for working capital. This digital investment is expected to amount to approximately SEK 2.6bn. Of this amount, approximately SEK 1.4bn will comprise costs that will be charged to the 2020-2024 period, and SEK 1.2bn will comprise capital expenditures. A positive sales and earnings impact is expected gradually from 2022. In the short term, costs are expected to be offset by savings in other areas.
The new Manufacturing Roadmap program will optimize and streamline all of Essity's approximately 60 wholly-owned facilities for world-class cost efficiency, quality and service levels. The program also includes logistics and distribution. Moreover, the program contributes to Essity's sustainability target relating to the reduction of carbon emissions in line with the Science Based Targets initiative.
Essity's Board of Directors is proposing a dividend of SEK 6.25 per share and that the dividend proposal will be addressed at an Extraordinary General Meeting on October 28, 2020.
During the third quarter of 2020, the Group's organic net sales declined 5.1%, of which volume accounted for -5.1% and price/mix for 0.0%. The Group's online sales increased due to strong growth in Personal Care and Consumer Tissue. Organic net sales in mature markets declined 7.7%. In emerging markets, which accounted for 36% of net sales, organic net sales decreased 0.8%
The COVID-19 pandemic has had both a positive and negative impact on Essity's business areas. Professional Hygiene's customer segments of hotel, restaurant, catering, commercial buildings as well as schools and universities were negatively affected by the lockdowns. Meanwhile, Professional Hygiene increased its sales of dispensers as a result of a greater focus on hygiene as many customers replaced air dryers to offer a more hygienic alternative. Moreover, Essity's wirelessly connected dispenser with sensor technology, Tork EasyCube®, shows that consumption per person of paper hand towels, soap and hand sanitizer has increased during the COVID-19 pandemic. As a result of rising demand, Professional Hygiene has increased delivery capacity for hand sanitizers. As lockdowns have forced consumers to spend more time in the home, demand for Consumer Tissue has been positively impacted while this has led to temporarily lower consumption for Personal Care. Eventually, the COVID-19 pandemic may lead to increased demand for the company's leading hygiene and health products as a result of increased awareness of the importance of hygiene and health.
During the third quarter, Essity launched several innovations that has strengthened its customer and consumer offering and improve the product mix. In Feminine Care in Latin America, with the leading Nosotras and Saba brands, we launched washable, absorbent underwear. In Incontinence Products, TENA SmartCare was launched, a digital solution for continence care in the home and in healthcare, which makes life easier and better for users, relatives and caregivers. We also expanded our product offering to include face masks within retail and under our leading global brand Tork in Professional Hygiene.
The Group's adjusted gross margin for the third quarter of 2020 increased 2.4 percentage points, compared with the corresponding period a year ago, to 32.4%. The gross margin was positively impacted by a better mix, lower raw material and energy costs and costs savings. Continuous cost savings amounted to SEK 235m. Lower volumes for the Group and lower prices for the Consumer Tissue business area had a negative impact on the gross margin. Adjusted EBITA decreased 1% compared with the year-earlier period. The Group's adjusted EBITA margin rose 1.6 percentage points to 14.4%. Sales and marketing costs increased as a share of net sales. Adjusted return on capital employed rose 0.4 percentage points to 14.7%. Earnings per share amounted to SEK 3.22.
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 2 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
ADJUSTED EARNINGS TREND
SEKm | 2009 | 1909 | % | 2020:3 | 2019:3 | % |
Net sales | 90,796 | 95,289 | -5 | 28,677 | 32,565 | -12 |
Cost of goods sold1 | -61,312 | -67,879 | -19,389 | -22,793 | ||
Adjusted gross profit1 | 29,484 | 27,410 | 8 | 9,288 | 9,772 | -5 |
Sales, general and administration1 | -16,250 | -16,312 | -5,169 | -5,596 | ||
Adjusted operating profit before amortization of acquisition-related intangible | ||||||
assets (EBITA)1 | 13,234 | 11,098 | 19 | 4,119 | 4,176 | -1 |
Amortization of acquisition-related intangible assets | -610 | -576 | -201 | -196 | ||
Adjusted operating profit1 | 12,624 | 10,522 | 20 | 3,918 | 3,980 | -2 |
Financial items | -786 | -1,006 | -184 | -320 | ||
Adjusted profit before tax1 | 11,838 | 9,516 | 24 | 3,734 | 3,660 | 2 |
Adjusted Income taxes1 | -3,061 | -1,809 | -1,049 | -730 | ||
Adjusted profit for the period1 | 8,777 | 7,707 | 14 | 2,685 | 2,930 | -8 |
1 Excluding items affecting comparability; for amounts see page 12. | ||||||
Adjusted margins (%) | ||||||
Gross margin1 | 32.5 | 28.8 | 32.4 | 30.0 | ||
EBITA margin1 | 14.6 | 11.6 | 14.4 | 12.8 | ||
Operating margin1 | 13.9 | 11.0 | 13.7 | 12.2 | ||
Financial net margin | -0.9 | -1.1 | -0.6 | -1.0 | ||
Profit margin1 | 13.0 | 9.9 | 13.1 | 11.2 | ||
Income taxes1 | -3.4 | -1.9 | -3.7 | -2.2 | ||
Net margin1 | 9.6 | 8.0 | 9.4 | 9.0 | ||
1Excluding items affecting comparability; for amounts see page 12. |
ADJUSTED EBITA BY BUSINESS AREA
SEKm | 2009 | 1909 | % | 2020:3 | 2019:3 | % |
Personal Care | 5,282 | 4,990 | 6 | 1,805 | 1,739 | 4 |
Consumer Tissue | 6,110 | 3,554 | 72 | 1,894 | 1,319 | 44 |
Professional Hygiene | 2,508 | 3,055 | -18 | 634 | 1,288 | -51 |
Other | -666 | -501 | -214 | -170 | ||
Total1 | 13,234 | 11,098 | 19 | 4,119 | 4,176 | -1 |
1 Excluding items affecting comparability; for amounts see page 12. |
ADJUSTED OPERATING PROFIT BY BUSINESS AREA
SEKm | 2009 | 1909 | % | 2020:3 | 2019:3 | % |
Personal Care | 4,705 | 4,447 | 6 | 1,614 | 1,554 | 4 |
Consumer Tissue | 6,106 | 3,549 | 72 | 1,894 | 1,317 | 44 |
Professional Hygiene | 2,479 | 3,026 | -18 | 624 | 1,278 | -51 |
Other | -666 | -500 | -214 | -169 | ||
Total1 | 12,624 | 10,522 | 20 | 3,918 | 3,980 | -2 |
1Excluding items affecting comparability; for amounts see page 12. |
OPERATING CASH FLOW BY BUSINESS AREA
SEKm | 2009 | 1909 | % | 2020:3 | 2019:3 | % |
Personal Care | 5,352 | 4,852 | 10 | 2,016 | 2,003 | 1 |
Consumer Tissue | 5,037 | 3,013 | 67 | 515 | 986 | -48 |
Professional Hygiene | 2,414 | 3,315 | -27 | 783 | 1,957 | -60 |
Other | -907 | -294 | -245 | 62 | ||
Total | 11,896 | 10,886 | 9 | 3,069 | 5,008 | -39 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 3 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
SEKm 35,000
30,000
25,000
20,000
15,000
10,000
5,000
0
Net sales
GROUP
NET SALES AND EARNINGS
January-September 2020 compared with the corresponding period a year ago
Net sales declined 4.7% compared with the corresponding period a year ago to SEK 90,796m (95,289). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, declined 2.4%, of which volume accounted for -3.1% and price/mix for 0.7%. Sales were negatively impacted by the COVID-19 pandemic and the related lockdowns. Organic net sales declined 4.3% in mature markets and increased 1.2% in emerging markets. Emerging markets accounted for 36% of net sales. Exchange rate effects reduced net sales by 2.2%. Acquisitions increased net sales by 0.1% and were largely attributable to the acquisition of the medical
SEKm | Adjusted EBITA and margin |
6,000 | 18% |
5,000 | 16% |
14% | |
4,000 | 12% |
3,000 | 10% |
8% | |
2,000 | 6% |
1,000 | 4% |
2% | |
0 | 0% |
Excluding items affecting comparability
Change in net sales (%)
2009 vs | 20:3 vs | |
1909 | 19:3 | |
Total | -4.7 | -11.9 |
Volume | -3.1 | -5.1 |
Price/mix | 0.7 | 0.0 |
Currency | -2.2 | -7.0 |
Acquisitions | 0.1 | 0.2 |
Divestments | -0.2 | 0.0 |
Change in adjusted EBITA (%) | ||
2009 vs | 20:3 vs | |
1909 | 19:3 | |
Total | 19 | -1 |
Volume | -10 | -14 |
Price/mix | 5 | -2 |
Raw materials | 34 | 24 |
Energy | 3 | 2 |
Currency | -2 | -8 |
Other | -11 | -3 |
-
SEKm | Adjusted profit before tax |
6,000 |
5,000
4,000
3,000
2,000
1,000
0
Excluding items affecting comparability
Cash flow from current
SEKm operations
5,000
4,000
3,000
2,000
1,000
0
solutions company ABIGO Medical AB. Divestment of a partly owned company in Turkey reduced net sales by 0.2%.
The Group's adjusted gross margin increased 3.7 percentage points to 32.5% (28.8) compared with the corresponding period a year ago. The gross margin was positively impacted by a better mix, lower raw material and energy costs and cost savings. Lower raw material and energy costs increased the gross margin by 4.5 percentage points. The lower raw material costs were primarily the result of lower pulp prices. Continuous cost savings amounted to SEK 622m. Lower volumes and higher distribution costs for the Group and lower prices for the Consumer Tissue business area had a negative impact on the gross margin. The Group's adjusted EBITA margin rose 3.0 percentage points to 14.6% (11.6). Sales and marketing costs increased as a share of net sales.
Adjusted operating profit before amortization of acquisition-related intangible assets (adjusted EBITA) increased 19% (22% excluding currency translation effects, acquisitions and divestments) to SEK 13,234m (11,098).
Items affecting comparability amounted to SEK -57m(-711) and were impacted positively as a result of the Dutch pension plan being reclassified from a defined benefit to a defined contribution scheme during the second quarter of 2020 due to a contract renegotiation. Restructuring costs and impairments had a negative impact.
Financial items decreased to SEK -786m(-1,006). Lower interest and lower average net debt had a positive impact.
Adjusted profit before tax increased 24% (27% excluding currency translation effects, acquisitions and divestments) and amounted to SEK 11,838m (9,516).
The tax expense, excluding effects of items affecting comparability, was SEK 3,061m (1,809).
Adjusted profit for the period increased 14% (17% excluding currency translation effects, acquisitions and divestments) and amounted to SEK 8,777m (7,707).
Profit for the period increased 22% (25% excluding currency translation effects, acquisitions and divestments) to SEK 8,718m (7,166). Earnings per share were SEK 10.80 (9.25). The adjusted earnings per share were SEK 11.50 (10.59).
The adjusted return on capital employed was 15.7% (12.8). The adjusted return on equity was 18.5% (20.0).
Third quarter of 2020 compared with the corresponding period a year ago
Net sales declined 11.9% compared with the corresponding period a year ago to SEK 28,677m (32,565). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, declined 5.1%, of which volume accounted for -5.1% and price/mix for 0.0%. Sales were negatively affected by the COVID-19 pandemic and related lockdowns. Organic net sales declined 7.7% in mature markets and 0.8% in emerging markets. Emerging markets accounted for 36% of net sales. Exchange rate effects reduced net sales by 7.0%. Acquisitions increased net sales by 0.2% and were largely attributable to the acquisition of ABIGO Medical AB.
The Group's adjusted gross margin for the third quarter of 2020 increased 2.4 percentage points to 32.4% (30.0) compared with the corresponding period a year ago. The gross margin was positively impacted by a better mix, lower raw material and energy costs and cost savings. Lower raw material and energy costs increased the gross margin by 3.4 percentage points. The lower raw material costs were primarily the result of lower pulp prices. Continuous cost savings amounted to SEK 235m. Lower volumes for the Group and lower prices for the Consumer
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 4 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
Tissue business area had a negative impact on the gross margin. The Group's adjusted EBITA margin rose 1.6 percentage points to 14.4% (12.8). Sales and marketing costs increased as a share of net sales.
Adjusted operating profit before amortization of acquisition-related intangible assets (adjusted EBITA) decreased 1% (increased 7% excluding currency translation effects, acquisitions and divestments) to SEK 4,119m (4,176).
Adjusted profit before tax increased 2% (10% excluding currency translation effects, acquisitions and divestments) and amounted to SEK 3,734m (3,660).
Profit for the period decreased 5% (increased 3% excluding currency translation effects, acquisitions and divestments) and amounted to SEK 2,600m (2,736). Earnings per share were SEK 3.22 (3.53). The adjusted earnings per share were SEK 3.55 (3.99).
The adjusted return on capital employed was 14.7% (14.3). The adjusted return on equity was 16.5% (20.1).
CASH FLOW AND FINANCING
January-September 2020 compared with the corresponding period a year ago
The operating cash surplus amounted to SEK 18,469m (16,279). The cash flow effect of changes in working capital was SEK -1,713m(-133). Investments in non-current assets, net, excluding investments in operating assets through leases, amounted to SEK -3,975m(-3,761). Operating cash flow before investments in operating assets through leases amounted to SEK 12,111m (11,219). Investments in operating assets through leases amounted to
SEK -215m(-333). Operating cash flow was SEK 11,896m (10,886).
Financial items decreased to SEK -786m(-1,006). Lower interest and lower average net debt had a positive impact.
Tax payments had an impact on cash flow of SEK -2,581m(-359). A decision in a tax case in
Sweden reduced the tax payment by approximately SEK 1.1bn in 2019.
The net sum of acquisitions and divestments was SEK -749m (210). Net cash flow totaled
SEK 7,513m (5,402).
Net debt decreased by SEK 5,246m during the period and amounted to SEK 45,694m. Excluding pension liabilities, net debt amounted to SEK 40,580m. Net cash flow reduced net debt by SEK 7,513m. Fair value measurement of pension assets and updated assumptions and assessments that affect measurement of the net pension liability, together with fair value measurement of financial instruments, increased net debt by SEK 2,733m. Exchange rate movements reduced net debt by SEK 797m. Investments in non-operating assets through leases increased net debt by SEK 331m. The debt/equity ratio was 0.69 (0.96). Excluding pension liabilities, the debt/equity ratio was 0.62 (0.86). The debt payment capacity was 45% (31). Net debt in relation to adjusted EBITDA amounted to 1.85 (2.76).
EQUITY
January-September 2020
The Group's equity increased by SEK 3,136m during the period, to SEK 65,937m. Net profit for the period increased equity by SEK 8,718m. Equity decreased net after tax by SEK 2,157m as a result of fair value measurement of pension assets and updated assumptions and assessments that affect the valuation of the pension liability. Fair value measurement of financial instruments increased equity by SEK 160m after tax. Exchange rate movements, including the effect of hedges of net foreign investments, after tax, reduced equity by SEK 3,231m. Other items decreased equity by SEK 354m.
TAX
January-September 2020
A tax expense of SEK 3,061m was reported, excluding items affecting comparability. The reported tax expense corresponds to a tax rate of about 25.9% for the period. The tax expense including items affecting comparability was SEK 3,063m, corresponding to a tax rate of 26.0% for the period.
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 5 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
DIVIDEND
The Board of Directors is proposing a dividend of SEK 6.25 (5.75) per share or SEK 4,390m (4,038). The record date for entitlement to receive dividends is proposed as October 30, 2020.
EVENTS DURING THE QUARTER
Essity proposes share dividend of SEK 6.25
On September 28, 2020, Essity announced that the company's Board of Directors has proposed a dividend of SEK 6.25 per share and that the dividend proposal be addressed at an Extraordinary General Meeting on October 28, 2020. During the spring, the Board of Directors withdrew its original dividend proposal. This was a consequence of the great uncertainty surrounding COVID-19. Despite Essity's highly robust income statement and balance sheet for 2019, there were grounds to exercise particular caution. Essity has remained strong with a continued healthy cash flow in 2020. The company has a strong balance sheet and financial flexibility. The company has not utilized the government's furlough scheme.
Essity will convene an Extraordinary General Meeting to be held on October 28, 2020. Under the current circumstances, the Meeting will use a format with advance voting, in accordance with the temporary legislation authorized by the Swedish Parliament, whereby votes are submitted to the company prior to the Meeting.
EVENTS AFTER THE QUARTER
Essity raises target for adjusted return on capital employed to above 17% by 2025
On October 22, 2020, Essity announced that the company is raising its target for adjusted return on capital employed to above 17% by 2025. The previous target of above 15% for adjusted return on capital employed has been achieved during the last 12 months. The raised target will be achieved through the continued execution of Essity's existing strategy, an accelerated digital transformation and further streamlining of production, logistics and distribution. Other financial targets remain unchanged.
Essity's innovation-driven category and channel strategy with leading brands combined with comprehensive efficiency improvements have contributed during the past three years to good organic sales growth and a gradual increase in profitability. Structural profitability in Consumer Tissue has been raised for example as a consequence of a higher share of own brands, a focus on growth in segments with high margins, successful innovations and more efficient production. In Baby Care, work is continuing to improve profitability and during the year we have, for example, exited underperforming positions in North Africa and Russia. In Incontinence Products, Medical Solutions and Feminine Care the focus remains on growth. In Professional Hygiene, an increased awareness of the importance of hygiene and health is eventually expected to result in rising demand.
Essity's digital transformation will accelerate in the years ahead through a new digital platform. This will further strengthen the Group's customer and consumer offerings, generate significant cost savings and reduce the need for working capital. This digital investment is expected to amount to approximately SEK 2.6bn. Of this amount, approximately SEK 1.4bn will comprise costs that will be charged to the 2020-2024 period, and SEK 1.2bn will comprise capital expenditures. A positive sales and earnings impact is expected gradually from 2022. In the short term, costs are expected to be offset by savings in other areas. The digital platform will enable automation in all parts of the value chain, simplification and economies of scale, and greater visibility and predictability based on high-quality data collection and advanced analytics.
The new Manufacturing Roadmap program will optimize and streamline all of Essity's approximately 60 wholly-owned facilities for world-class cost efficiency, quality and service levels. The program also includes logistics and distribution. Moreover, the program contributes to Essity's sustainability target relating to the reduction of carbon emissions in line with the Science Based Targets initiative.
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 6 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
Essity divests partly owned company in Tunisia
On October 21, 2020, Essity announced that the company divests its 49% stake in Sancella Tunisia to the other owner Sotupa. Sancella Tunisia offers a range of Essity's products and brands in Tunisia, Algeria, Morocco, and Libya. Essity will retain a presence on these markets through license and distribution agreements.
In 2019, Sancella Tunisia reported net sales of SEK 575m (TND 154m). The divestment is expected to give rise to a gain of approximately SEK 25m, which will be recognized as an item
affecting comparability when the transaction is completed. The transaction is subject to approval by Tunisian authorities and is expected to be completed during Q4 2020.
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 7 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
Share of Group, net sales
2009
38%
Share of Group, adjusted EBITA
2009
38%
SEKm | Net sales |
14,000
12,000
10,000
8,000
6,000
4,000
2,000
0
Adjusted EBITA and margin | % |
SEKm | |
2,500 | 18 |
2,000 | 16 |
14 | |
1,500 | 12 |
10 | |
1,000 | 8 |
6 | |
500 | 4 |
2 | |
0 | 0 |
Change in net sales (%)
2009 vs | 20:3 vs | |
1909 | 19:3 | |
Total | -4.1 | -9.0 |
Volume | -2.3 | -3.2 |
Price/mix | 1.5 | 1.7 |
Currency | -3.2 | -8.0 |
Acquisitions | 0.3 | 0.5 |
Divestments | -0.4 | 0.0 |
Change in adjusted EBITA (%)
2009 vs | 20:3 vs | |
1909 | 19:3 | |
Total | 6 | 4 |
Volume | -8 | -10 |
Price/mix | 8 | 10 |
Raw materials | 10 | 11 |
Energy | 0 | 0 |
Currency | -3 | -10 |
Other | -1 | 3 |
PERSONAL CARE
SEKm | 2009 | 1909 | % | 2020:3 | 2019:3 | % |
Net sales | 34,435 | 35,915 | -4 | 11,115 | 12,216 | -9 |
Adjusted gross profit margin, %* | 41.1 | 39.1 | 41.8 | 39.3 | ||
Adjusted EBITA* | 5,282 | 4,990 | 6 | 1,805 | 1,739 | 4 |
Adjusted EBITA margin, %* | 15.3 | 13.9 | 16.2 | 14.2 | ||
Adjusted operating profit* | 4,705 | 4,447 | 6 | 1,614 | 1,554 | 4 |
Adjusted operating margin, %* | 13.7 | 12.4 | 14.5 | 12.7 | ||
Adjusted return on capital employed, %* | 15.8 | 15.1 | 16.5 | 15.3 | ||
Operating cash flow | 5,352 | 4,852 | 2,016 | 2,003 |
*) Excluding restructuring costs, which are reported as items affecting comparability outside of the business area.
January-September 2020 compared with the corresponding period a year ago
Net sales declined 4.1% to SEK 34,435m (35,915). Organic net sales declined 0.8%, of which volume accounted for -2.3% and price/mix for 1.5%. Organic net sales in mature markets declined 2.5%. In emerging markets, which accounted for 36% of net sales, organic net sales increased 2.2%. Exchange rate effects reduced net sales by 3.2%. The divestment of a partly owned company in Turkey reduced net sales by 0.4%. Acquisitions increased net sales by 0.3% and related mainly to ABIGO Medical AB.
For Incontinence Products, with Essity's globally leading TENA brand, organic net sales increased 2.6%. Growth was related to Western Europe, North America and emerging markets. In Medical Solutions, organic net sales decreased 10.3%. Sales were negatively impacted by the COVID-19 pandemic and the related lockdowns. For Baby Care, organic net sales declined 4.5%, related to Western Europe and emerging markets. For Feminine Care, organic net sales increased 5.0%, related to emerging markets.
The adjusted gross margin increased 2.0 percentage points to 41.1% (39.1). The margin was positively impacted by higher prices, a better mix, lower raw material costs and cost savings. Lower raw material costs increased the margin by 1.4 percentage points. Lower volumes and higher distribution costs had a negative impact on the margin. The adjusted EBITA margin increased by 1.4 percentage points to 15.3% (13.9). Sales and marketing costs increased as a share of net sales. Adjusted EBITA increased 6% (9% excluding currency translation effects, acquisitions and divestments) to SEK 5,282m (4,990).
The operating cash surplus amounted to SEK 6,715m (6,500).
Third quarter of 2020 compared with the corresponding period a year ago
Net sales declined 9.0% to SEK 11,115m (12,216). Organic net sales declined 1.5%, of which volume accounted for -3.2% and price/mix for 1.7%. Organic net sales in mature markets declined 2.3%. In emerging markets, which accounted for 34% of net sales, organic net sales declined 0.3%. Exchange rate effects reduced net sales by 8.0%. Acquisitions increased net sales by 0.5%.
Sales were negatively affected by the COVID-19 pandemic as demand was temporarily impacted by the lockdowns as consumption decreased slightly when consumers spent more time in the home. For Incontinence Products, with Essity's globally leading TENA brand, organic net sales declined 0.3%. The decline was related to Western Europe and North America, while net sales increased in emerging markets. In Medical Solutions, organic net sales decreased 4.5%, which was a substantial improvement compared with the second quarter of 2020. For Baby Care, organic net sales declined 2.8% related to Western Europe and emerging markets. For Feminine Care, organic net sales increased 0.1%, related to emerging markets.
The adjusted gross margin increased 2.5 percentage points to 41.8% (39.3). The margin was positively impacted by higher prices, a better mix, lower raw material costs and cost savings. Lower raw material costs increased the margin by 1.5 percentage points. Lower volumes and higher distribution costs had a negative impact on the margin. The adjusted EBITA margin increased by 2.0 percentage points to 16.2% (14.2). Sales and marketing cost increased as a share of net sales. Adjusted EBITA rose 4% (14% excluding currency translation effects, acquisitions and divestments) to SEK 1,805m (1,739).
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 8 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
Share of Group, net sales
2009
41%
Share of Group, adjusted EBITA
2009
44%
SEKm | Net sales |
14,000 |
13,000
12,000
11,000
10,000
9,000
8,000
7,000
6,000
5,000
Adjusted EBITA and margin %
SEKm | |
2,500 | 18 |
16 | |
2,000 | 14 |
1,500 | 12 |
10 | |
1,000 | 8 |
6 | |
500 | 4 |
2 | |
0 | 0 |
Change in net sales (%)
2009 vs | 20:3 vs | |
1909 | 19:3 | |
Total | 1.4 | -4.8 |
Volume | 4.4 | 4.6 |
Price/mix | -0.8 | -2.6 |
Currency | -2.2 | -6.8 |
Acquisitions | 0.0 | 0.0 |
Divestments | 0.0 | 0.0 |
Change in adjusted EBITA (%)
2009 vs | 20:3 vs | |
1909 | 19:3 | |
Total | 72 | 44 |
Volume | 11 | 11 |
Price/mix | -9 | -23 |
Raw materials | 76 | 61 |
Energy | 8 | 6 |
Currency | -2 | -9 |
Other | -12 | -2 |
CONSUMER TISSUE
SEKm | 2009 | 1909 | % | 2020:3 | 2019:3 | % |
Net sales | 37,151 | 36,635 | 1 | 11,634 | 12,220 | -5 |
Adjusted gross profit margin, %* | 27.4 | 20.6 | 27.6 | 22.1 | ||
Adjusted EBITA* | 6,110 | 3,554 | 72 | 1,894 | 1,319 | 44 |
Adjusted EBITA margin, %* | 16.4 | 9.7 | 16.3 | 10.8 | ||
Adjusted operating profit* | 6,106 | 3,549 | 72 | 1,894 | 1,317 | 44 |
Adjusted operating margin, %* | 16.4 | 9.7 | 16.3 | 10.8 | ||
Adjusted return on capital employed, %* | 16.7 | 9.3 | 16.5 | 11.0 | ||
Operating cash flow | 5,037 | 3,013 | 515 | 986 |
*) Excluding restructuring costs, which are reported as items affecting comparability outside of the business area.
January-September 2020 compared with the corresponding period a year ago
Net sales increased 1.4% to SEK 37,151m (36,635). Organic net sales increased 3.6%. Volumes increased by 4.4% and the price/mix decreased 0.8%. Organic net sales increased 2.5% in mature markets. In emerging markets, which accounted for 46% of net sales, organic net sales increased by 5.0%. Exchange rate effects decreased net sales by 2.2%.
The adjusted gross margin increased 6.8 percentage points to 27.4% (20.6). The gross margin was positively impacted by higher volumes, a better mix, lower raw material and energy costs and cost savings. Lower raw material and energy costs increased the gross margin by 8.0 percentage points. The lower raw material costs were mainly the result of lower pulp prices. Higher distribution costs and lower prices had a negative impact on the margin. The adjusted EBITA margin increased by 6.7 percentage points to 16.4% (9.7). Sales and marketing costs as a share of net sales were in line with the year-earlier period.
Adjusted EBITA increased 72% (74% excluding currency translation effects, acquisitions and divestments) to SEK 6,110m (3,554).
The operating cash surplus totaled SEK 8,189m (5,550).
Third quarter of 2020 compared with the corresponding period a year ago
Net sales decreased 4.8% to SEK 11,634m (12,220). Organic net sales increased 2.0%. Volumes increased by 4.6% and the price/mix declined by 2.6% as a result of lower prices and a better mix. Organic net sales increased 0.9% in mature markets. In emerging markets, which accounted for 45% of net sales, organic net sales increased by 3.4%. Exchange rate effects reduced net sales by 6.8%.
The adjusted gross margin increased 5.5 percentage points to 27.6% (22.1). The gross margin was positively impacted by higher volumes, a better mix, cost savings and lower raw material and energy costs. Lower raw material and energy costs increased the gross margin by 7.0 percentage points. The lower raw material costs were mainly the result of lower pulp prices. Lower prices had a negative impact on the margin. The adjusted EBITA margin increased by 5.5 percentage points to 16.3% (10.8). Sales and marketing costs as a share of net sales were in line with the year-earlier period.
Adjusted EBITA increased 44% (53% excluding currency translation effects, acquisitions and divestments) to SEK 1,894m (1,319).
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 9 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
Share of Group, net sales
2009
21%
Share of Group, adjusted EBITA
PROFESSIONAL HYGIENE
SEKm | 2009 | 1909 | % | 2020:3 | 2019:3 | % |
Net sales | 19,202 | 22,740 | -16 | 5,930 | 8,131 | -27 |
Adjusted gross profit margin, %* | 26.9 | 25.6 | 24.1 | 27.9 | ||
Adjusted EBITA* | 2,508 | 3,055 | -18 | 634 | 1,288 | -51 |
Adjusted EBITA margin, %* | 13.1 | 13.4 | 10.7 | 15.8 | ||
Adjusted operating profit* | 2,479 | 3,026 | -18 | 624 | 1,278 | -51 |
Adjusted operating margin, %* | 12.9 | 13.3 | 10.5 | 15.7 | ||
Adjusted return on capital employed, %* | 16.7 | 17.8 | 11.2 | 21.2 | ||
Operating cash flow | 2,414 | 3,315 | 783 | 1,957 |
*) Excluding restructuring costs, which are reported as items affecting comparability outside of the business area.
SEKm
9,000
8,000
7,000
6,000
5,000
4,000
3,000
2,000
1,000
0
2009
18%
Net sales
January-September 2020 compared with the corresponding period a year ago
Net sales declined 15.6% to SEK 19,202m (22,740). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, declined 14.4%. Sales were negatively impacted by the COVID-19 pandemic and related lockdowns. Volumes declined by 16.7%. The price/mix increased 2.3% as a result of higher prices and a better mix. Organic net sales declined 14.1% in mature markets. In emerging markets, which accounted for 19% of net sales, organic net sales declined by 15.7%. Exchange rate effects reduced net sales by 1.2%.
The adjusted gross margin increased 1.3 percentage points to 26.9% (25.6). The gross margin was positively impacted by higher prices, a better mix, lower raw material and energy costs and cost savings. Lower raw material and energy costs increased the gross margin by 3.0 percentage points. The lower raw material costs were mainly the result of lower prices for recovered paper and pulp. Lower volumes and higher distribution costs had a negative impact on the margin. The adjusted EBITA margin decreased by 0.3 percentage points to 13.1% (13.4). Sales and marketing costs increased as a share of net sales.
Adjusted EBITA decreased 18% (17% excluding currency translation effects, acquisitions and divestments) to SEK 2,508m (3,055).
The operating cash surplus was SEK 4,123m (4,623).
Adjusted EBITA and margin
SEKm | % |
1,500 | 20 |
18 | |
16 | |
1,000 | 14 |
12 | |
10 | |
500 | 8 |
6 | |
4 | |
2 | |
0 | 0 |
Change in net sales (%)
2009 vs | 20:3 vs | |
1909 | 19:3 | |
Total | -15.6 | -27.1 |
Volume | -16.7 | -22.6 |
Price/mix | 2.3 | 1.2 |
Currency | -1.2 | -5.7 |
Acquisitions | 0.0 | 0.0 |
Divestments | 0.0 | 0.0 |
Change in adjusted EBITA (%)
2009 vs | 20:3 vs | |
1909 | 19:3 | |
Total | -18 | -51 |
Volume | -35 | -42 |
Price/mix | 12 | 4 |
Raw materials | 19 | 0 |
Energy | 1 | -1 |
Currency | -1 | -4 |
Other | -14 | -8 |
Third quarter of 2020 compared with the corresponding period a year ago
Net sales declined 27.1% to SEK 5,930m (8,131). Organic net sales, which exclude exchange rate effects, acquisitions and divestments, declined 21.4%. Sales were negatively impacted by the COVID-19 pandemic and the related lockdowns and inventory adjustments following stockpiling among distributors in March 2020. The negative impact of lockdowns was primarily on demand in the customer segments of hotel, restaurant, catering, commercial buildings as well as schools and universities. Meanwhile, sales of dispensers increased as a result of a greater focus on hygiene as many customers replaced air dryers to offer a more hygienic alternative. Moreover, Essity's wirelessly connected dispenser with sensor technology showed that consumption per person of paper hand towels, soap and hand sanitizer has increased during the COVID-19 pandemic. Volumes declined by 22.6%. The price/mix increased 1.2% as a result of a better mix. Organic net sales declined 22.7% in mature markets. In emerging markets, which accounted for 20% of net sales, organic net sales declined by 17.2%. Exchange rate effects reduced net sales by 5.7%.
The adjusted gross margin declined 3.8 percentage points to 24.1% (27.9). The gross margin was positively impacted by a better mix and cost savings. Lower volumes had a negative impact on the margin. Raw material costs remained stable. The adjusted EBITA margin declined by 5.1 percentage points to 10.7% (15.8). Sales and marketing costs increased as a share of net sales.
Adjusted EBITA declined 51% (47% excluding currency translation effects, acquisitions and divestments) to SEK 634m (1,288).
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 10 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
DISTRIBUTION OF SHARES
September 30, 2020 | Class A | Class B | Total |
Registered number of shares | 61,735,252 | 640,607,237 | 702,342,489 |
At the end of the period, the proportion of Class A shares was 8.8%. During the third quarter, 1,711 Class A shares were converted into Class B shares at the request of shareholders. The total number of votes in the company amounts to 1,257,959,757.
FUTURE REPORTS
The Year-end Report for 2020 will be published on January 27, 2021. Essity's Annual Report for 2020 will be published during the week starting March 1, 2021. In 2021, interim reports will be published on April 23, July 16 and October 22.
EXTRAORDINARY GENERAL MEETING
An Extraordinary General Meeting of Essity will be held on October 28, 2020.
ANNUAL GENERAL MEETING
Essity's Annual General Meeting will be held in Stockholm on March 25, 2021.
INVITATION TO PRESENTATION OF THE THIRD QUARTER REPORT FOR 2020
In conjunction with publication, a telephone and web presentation will be held where President and CEO Magnus Groth will present and answer questions.
Presentation
Date: Thursday, October 22, 2020
Time: 9:00 a.m.
Link to web presentation:https://essity.videosync.fi/2020-10-22-q3
To participate by telephone, call: +44 (0)207 192 80 00, +1 631 510 74 95 or +46 (0)8 506 921 80. Please call well in advance of the start of the presentation. Specify "Essity" or conference ID no. 5359628.
Stockholm, October 22, 2020
Essity Aktiebolag (publ)
Magnus Groth
President and CEO
For further information, please contact:
Fredrik Rystedt, CFO and Executive Vice President, +46 (0)8 788 51 31
Johan Karlsson, Vice President Investor Relations, Group Function Communications, +46 (0)8 788 51 30
Joséphine Edwall Björklund, Senior Vice President, Group Function Communications, +46 (0)8 788 52 34
Per Lorentz, Vice President Corporate Communications, Group Function Communications, +46 (0)8 788 52 51
NB:
This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation . This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. The information was submitted for publication, through the agency of the contact person set out below, at 7:00 a.m. CET on October 22, 2020. This interim report has not been reviewed by the company's auditors.
Karl Stoltz, Media Relations Manager, +46 (0)8 788 51 55
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 11 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
CONDENSED STATEMENT OF PROFIT OR LOSS
SEKm | 2020:3 | 2019:3 | 2020:2 | 2009 | 1909 |
Net sales | 28,677 | 32,565 | 28,407 | 90,796 | 95,289 |
Cost of goods sold1,2 | -19,389 | -22,793 | -19,260 | -61,312 | -67,879 |
Items affecting comparability - cost of goods sold2 | -94 | 23 | -100 | -203 | -232 |
Gross profit | 9,194 | 9,795 | 9,047 | 29,281 | 27,178 |
Sales, general and administration1,2 | -5,181 | -5,594 | -5,381 | -16,311 | -16,333 |
Items affecting comparability - sales, general and administration2 | -7 | -224 | 161 | 146 | -479 |
Share of profits of associates and joint ventures | 12 | -2 | 16 | 61 | 21 |
Operating profit before amortization of acquisition-related | |||||
intangible assets (EBITA) | 4,018 | 3,975 | 3,843 | 13,177 | 10,387 |
Amortization of acquisition-related intangible assets | -201 | -196 | -208 | -610 | -576 |
Operating profit | 3,817 | 3,779 | 3,635 | 12,567 | 9,811 |
Financial items | -184 | -320 | -283 | -786 | -1,006 |
Profit before tax | 3,633 | 3,459 | 3,352 | 11,781 | 8,805 |
Income taxes | -1,033 | -723 | -844 | -3,063 | -1,639 |
Profit for the period | 2,600 | 2,736 | 2,508 | 8,718 | 7,166 |
Earnings attributable to: | |||||
Owners of the parent | 2,265 | 2,477 | 2,088 | 7,588 | 6,500 |
Non-controlling interests | 335 | 259 | 420 | 1,130 | 666 |
Earnings per share, SEK - owners of the parent | |||||
- before and after dilution effects | 3.22 | 3.53 | 2.97 | 10.80 | 9.25 |
Average no. of shares before and after dilution, millions | 702.3 | 702.3 | 702.3 | 702.3 | 702.3 |
1Of which, depreciation/amortization | -1,773 | -1,879 | -1,857 | -5,514 | -5,552 |
2Of which, impairment | -141 | 72 | -112 | -257 | 6 |
Gross margin | 32.1 | 30.1 | 31.8 | 32.2 | 28.5 |
EBITA margin | 14.0 | 12.2 | 13.5 | 14.5 | 10.9 |
Operating margin | 13.3 | 11.6 | 12.8 | 13.8 | 10.3 |
Financial net margin | -0.6 | -1.0 | -1.0 | -0.9 | -1.1 |
Profit margin | 12.7 | 10.6 | 11.8 | 12.9 | 9.2 |
Income taxes | -3.6 | -2.2 | -3.0 | -3.4 | -1.7 |
Net margin | 9.1 | 8.4 | 8.8 | 9.5 | 7.5 |
Excluding items affecting comparability: | |||||
Gross margin | 32.4 | 30.0 | 32.2 | 32.5 | 28.8 |
EBITA margin | 14.4 | 12.8 | 13.3 | 14.6 | 11.6 |
Operating margin | 13.7 | 12.2 | 12.6 | 13.9 | 11.0 |
Financial net margin | -0.6 | -1.0 | -1.0 | -0.9 | -1.1 |
Profit margin | 13.1 | 11.2 | 11.6 | 13.0 | 9.9 |
Income taxes | -3.7 | -2.2 | -2.9 | -3.4 | -1.9 |
Net margin | 9.4 | 9.0 | 8.7 | 9.6 | 8.0 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 12 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
SEKm | 2020:3 | 2019:3 | 2020:2 | 2009 | 1909 |
Profit for the period | 2,600 | 2,736 | 2,508 | 8,718 | 7,166 |
Other comprehensive income for the period | |||||
Items that may not be reclassified to the income statement | |||||
Actuarial gains/losses on defined benefit pension plans | 388 | -1,169 | -1,226 | -2,733 | -2,004 |
Fair value through other comprehensive income | 2 | 1 | 5 | 0 | 6 |
Income tax attributable to components in other comprehensive income | -85 | 222 | 302 | 576 | 444 |
305 | -946 | -919 | -2,157 | -1,554 | |
Items that have been or may be reclassified subsequently to the income statement | |||||
Cash flow hedges | |||||
Result from remeasurement of derivatives recognized in equity | 74 | -10 | 55 | -218 | -400 |
Transferred to profit or loss for the period | 130 | 68 | 176 | 427 | 54 |
Translation differences in foreign operations | -1,518 | 1,967 | -4,578 | -3,584 | 4,454 |
Gains/losses from hedges of net investments in foreign operations | 367 | -146 | 702 | 443 | -357 |
Other comprehensive income from associated companies | -2 | -5 | -22 | -12 | -15 |
Income tax attributable to components in other comprehensive income | -127 | 16 | -200 | -132 | 154 |
-1,076 | 1,890 | -3,867 | -3,076 | 3,890 | |
Other comprehensive income for the period, net of tax | -771 | 944 | -4,786 | -5,233 | 2,336 |
Total comprehensive income for the period | 1,829 | 3,680 | -2,278 | 3,485 | 9,502 |
Total comprehensive income attributable to: | |||||
Owners of the Parent company | 1,613 | 3,213 | -2,107 | 2,759 | 8,319 |
Non-controlling interests | 216 | 467 | -171 | 726 | 1,183 |
CONSOLIDATED STATEMENT OF CHANGE IN EQUITY
SEKm | 2009 | 1909 | |
Attributable to owners of the Parent company | |||
Value, January 1 | 54,125 | 47,141 | |
Total comprehensive income for the period | 2,759 | 8,319 | |
Dividend | 0 | -4,038 | |
Acquisition of holdings non-controlling interests | -1 | 0 | |
Private placement to non-controlling interests | 32 | 2 | |
Transferred to cost of hedged investments | -7 | 8 | |
Revaluation effect on acquisition of holdings non-controlling interests | -1 | 0 | |
Value, September 30 | 56,907 | 51,432 | |
Non-controlling interests | |||
Value, January 1 | 8,676 | 7,758 | |
Total comprehensive income for the period | 726 | 1,183 | |
Dividend | -436 | -343 | |
Private placement to non-controlling interests | 30 | 2 | |
Divestment of non-controlling interests | 35 | 0 | |
Acquisition of non-controlling interests | -1 | 0 | |
Value, September 30 | 9,030 | 8,600 | |
Total equity, value September 30 | 65,937 | 60,032 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 13 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
CONSOLIDATED OPERATING CASH FLOW STATEMENT
SEKm | 2009 | 1909 |
Operating cash surplus | 18,469 | 16,279 |
Change in working capital | -1,713 | -133 |
Investment in non-current assets, net | -3,975 | -3,761 |
Restructuring costs, etc. | -670 | -1,166 |
Operating cash flow before Investments in operating assets through leases | 12,111 | 11,219 |
Investments in operating assets through leases | -215 | -333 |
Operating cash flow | 11,896 | 10,886 |
Financial items | -786 | -1,006 |
Income taxes paid | -2,581 | -359 |
Other | 31 | 8 |
Cash flow from current operations | 8,560 | 9,529 |
Acquisitions of Group companies and other operations | -748 | -10 |
Divestments of Group companies and other operations | -1 | 220 |
Cash flow before transactions with shareholders | 7,811 | 9,739 |
Private placement to non-controlling interest | 60 | 4 |
Dividend to non-controlling interests | -358 | -303 |
Dividend | 0 | -4,038 |
Net cash flow | 7,513 | 5,402 |
Net debt at the start of the period | -50,940 | -54,404 |
Changed opening balance for net debt due to IFRS 16 Leases | 0 | -3,786 |
Net cash flow | 7,513 | 5,402 |
Remeasurements to equity | -2,733 | -1,998 |
Investments in non-operating assets through leases | -331 | -380 |
Translation differences | 797 | -2,738 |
Net debt at the end of the period | -45,694 | -57,904 |
Debt/equity ratio | 0.69 | 0.96 |
Debt payment capacity, % | 45 | 31 |
Net debt / EBITDA | 1.84 | 2.87 |
Net debt / Adjusted EBITDA | 1.85 | 2.76 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 14 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
CONSOLIDATED CASH FLOW STATEMENT
SEKm | 2009 | 1909 |
Operating activities | ||
Operating profit | 12,567 | 9,811 |
Adjustment for non-cash items1 | 5,914 | 6,218 |
Interest paid | -725 | -822 |
Interest received | 80 | 82 |
Other financial items | -190 | -338 |
Change in liabilities relating to restructuring programs, etc. | -840 | -908 |
Paid tax | -2,581 | -359 |
Cash flow from operating activities before changes in working capital | 14,225 | 13,684 |
Cash flow from changes in working capital | ||
Change in inventories | -2,734 | -611 |
Change in operating receivables | -169 | -936 |
Change in operating liabilities | 1,190 | 1,414 |
Cash flow from operating activities | 12,512 | 13,551 |
Investing activities | ||
Acquisitions of Group companies and other operations | -668 | -10 |
Divestments of Group companies and other operations | 0 | 6 |
Investments in intangible assets and property, plant and equipment | -4,028 | -3,910 |
Sale of property, plant and equipment | 65 | 185 |
Loans granted to external parties | 0 | -65 |
Repayment of loans from external parties | 22 | 0 |
Paid interest capitalized in intangible asset and property, plant and equipment | -11 | -36 |
Cash flow from investing activities | -4,620 | -3,830 |
Financing activities | ||
Private placement to non-controlling interests | 60 | 4 |
Dividend | 0 | -4,038 |
Proceeds from borrowings | 5,895 | 1,151 |
Repayment of borrowings | -9,109 | -5,490 |
Dividend to non-controlling interests | -358 | -303 |
Cash flow from financing activities | -3,512 | -8,676 |
Cash flow for the period | 4,380 | 1,045 |
Cash and cash equivalents at the beginning of the period | 2,928 | 3,008 |
Translation differences in cash and cash equivalents | -169 | 184 |
Cash and cash equivalents at the end of the period | 7,139 | 4,237 |
Cash flow from operating activities per share, SEK | 17.81 | 19.29 |
Reconciliation with consolidated operating cash flow statement | ||
Cash flow for the period | 4,380 | 1,045 |
Refund to external parties | -22 | 0 |
Repayment of borrowings | 9,109 | 5,490 |
Proceeds from borrowings | -5,895 | -1,151 |
Loans granted to external parties | 0 | 65 |
Impact from settlement of pension liability | 188 | 0 |
Investment through financial lease | -215 | -333 |
Net debt in acquired and divested operations | -81 | 214 |
Accrued interest | 49 | 72 |
Net cash flow according to consolidated operating cash flow statement | 7,513 | 5,402 |
1) Adjustment for non-cash items | ||
Depreciation/amortization and impairment of non-current assets | 5,771 | 5,546 |
Gain/loss on asset sales | -29 | -15 |
Impact from settlement of pension liability | -188 | 0 |
Gain/loss on divestments | 8 | 131 |
Non-cash items relating to efficiency program | -13 | 233 |
Other | 365 | 323 |
Total | 5,914 | 6,218 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 15 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
CONSOLIDATED BALANCE SHEET
SEKm | September 30, 2020 | December 31, 2019 |
Assets | ||
Goodwill | 34,281 | 34,581 |
Other intangible assets | 19,660 | 21,182 |
Property, plant and equipment | 55,314 | 56,900 |
Participation in joint ventures and associates | 876 | 865 |
Shares and participations | 7 | 8 |
Surplus in funded pension plans | 1,418 | 2,841 |
Non-current financial assets | 715 | 694 |
Deferred tax assets | 1,893 | 2,539 |
Other non-current assets | 768 | 704 |
Total non-current assets | 114,932 | 120,314 |
Inventories | 17,822 | 15,764 |
Trade receivables | 19,031 | 19,864 |
Current tax assets | 567 | 745 |
Other current receivables | 2,233 | 2,113 |
Current financial assets | 771 | 525 |
Non-current assets held for sale | 42 | 42 |
Cash and cash equivalents | 7,139 | 2,928 |
Total current assets | 47,605 | 41,981 |
Total assets | 162,537 | 162,295 |
Equity | ||
Share capital | 2,350 | 2,350 |
Reserves | 3,616 | 6,284 |
Retained earnings | 50,941 | 45,491 |
Attributable to owner of the Parent | 56,907 | 54,125 |
Non-controlling interests | 9,030 | 8,676 |
Total equity | 65,937 | 62,801 |
Liabilities | ||
Non-current financial liabilities | 40,627 | 43,079 |
Provisions for pensions | 6,532 | 5,866 |
Deferred tax liabilities | 6,047 | 6,545 |
Other non-current provisions | 447 | 541 |
Other non-current liabilities | 147 | 183 |
Total non-current liabilities | 53,800 | 56,214 |
Current financial liabilities | 8,578 | 8,983 |
Trade payables | 15,089 | 15,802 |
Current tax liabilities | 2,373 | 2,432 |
Current provisions | 788 | 1,065 |
Other current liabilities | 15,972 | 14,998 |
Total current liabilities | 42,800 | 43,280 |
Total liabilities | 96,600 | 99,494 |
Total equity and liabilities | 162,537 | 162,295 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 16 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
CONSOLIDATED BALANCE SHEET (cont.)
SEKm | September 30, 2020 | December 31, 2019 |
Debt/equity ratio | 0.69 | 0.81 |
Equity/assets ratio | 35% | 33% |
Equity | 65,937 | 62,801 |
Equity per share | 94 | 89 |
Return on equity | 18.4% | 17.4% |
Return on equity excluding items affecting comparability | 18.5% | 18.4% |
Capital employed | 111,631 | 113,741 |
- of which working capital | 8,212 | 6,782 |
Return on capital employed* | 15.6% | 13.2% |
Return on capital employed* excluding items affecting comparability | 15.7% | 13.8% |
Net debt | 45,694 | 50,940 |
Provisions for restructuring costs are included in the balance sheet as follows | ||
-Othernon-current provisions | 115 | 184 |
-Other current provisions | 337 | 603 |
*) rolling 12 months
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 17 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
NET SALES (business area reporting)
SEKm | 2009 | 1909 | 2020:3 | 2020:2 | 2020:1 | 2019:4 | 2019:3 | 2019:2 |
Personal Care | 34,435 | 35,915 | 11,115 | 10,651 | 12,669 | 12,425 | 12,216 | 12,164 |
Consumer Tissue | 37,151 | 36,635 | 11,634 | 12,437 | 13,080 | 13,269 | 12,220 | 12,167 |
Professional Hygiene | 19,202 | 22,740 | 5,930 | 5,315 | 7,957 | 7,991 | 8,131 | 7,742 |
Other | 8 | -1 | -2 | 4 | 6 | 1 | -2 | -5 |
Total net sales | 90,796 | 95,289 | 28,677 | 28,407 | 33,712 | 33,686 | 32,565 | 32,068 |
ADJUSTED EBITA (business area reporting)
SEKm | 2009 | 1909 | 2020:3 | 2020:2 | 2020:1 | 2019:4 | 2019:3 | 2019:2 |
Personal Care | 5,282 | 4,990 | 1,805 | 1,438 | 2,039 | 1,756 | 1,739 | 1,711 |
Consumer Tissue | 6,110 | 3,554 | 1,894 | 2,124 | 2,092 | 1,767 | 1,319 | 1,166 |
Professional Hygiene | 2,508 | 3,055 | 634 | 481 | 1,393 | 1,408 | 1,288 | 1,026 |
Other | -666 | -501 | -214 | -261 | -191 | -189 | -170 | -171 |
Total adjusted EBITA | 13,234 | 11,098 | 4,119 | 3,782 | 5,333 | 4,742 | 4,176 | 3,732 |
ADJUSTED OPERATING PROFIT (business area reporting)
SEKm | 2009 | 1909 | 2020:3 | 2020:2 | 2020:1 | 2019:4 | 2019:3 | 2019:2 |
Personal Care | 4,705 | 4,447 | 1,614 | 1,241 | 1,850 | 1,567 | 1,554 | 1,529 |
Consumer Tissue | 6,106 | 3,549 | 1,894 | 2,122 | 2,090 | 1,765 | 1,317 | 1,164 |
Professional Hygiene | 2,479 | 3,026 | 624 | 472 | 1,383 | 1,398 | 1,278 | 1,016 |
Other | -666 | -500 | -214 | -261 | -191 | -190 | -169 | -170 |
Total adjusted operating profit1 | 12,624 | 10,522 | 3,918 | 3,574 | 5,132 | 4,540 | 3,980 | 3,539 |
Financial items | -786 | -1,006 | -184 | -283 | -319 | -303 | -320 | -344 |
Profit before tax1 | 11,838 | 9,516 | 3,734 | 3,291 | 4,813 | 4,237 | 3,660 | 3,195 |
Income taxes | -3,061 | -1,809 | -1,049 | -823 | -1,189 | -1,178 | -730 | -482 |
Net profit for the period2 | 8,777 | 7,707 | 2,685 | 2,468 | 3,624 | 3,059 | 2,930 | 2,713 |
1Excluding items affecting comparability before tax amounting to: | -57 | -711 | -101 | 61 | -17 | -2 | -201 | -322 |
2Excluding items affecting comparability after tax amounting to: | -59 | -541 | -85 | 40 | -14 | -13 | -194 | -212 |
ADJUSTED EBITA MARGIN (business area reporting)
% | 2009 | 1909 | 2020:3 | 2020:2 | 2020:1 | 2019:4 | 2019:3 | 2019:2 |
Personal Care | 15.3 | 13.9 | 16.2 | 13.5 | 16.1 | 14.1 | 14.2 | 14.1 |
Consumer Tissue | 16.4 | 9.7 | 16.3 | 17.1 | 16.0 | 13.3 | 10.8 | 9.6 |
Professional Hygiene | 13.1 | 13.4 | 10.7 | 9.0 | 17.5 | 17.6 | 15.8 | 13.3 |
STATEMENT OF PROFIT OR LOSS
SEKm | 2020:3 | 2020:2 | 2020:1 | 2019:4 | 2019:3 |
Net sales | 28,677 | 28,407 | 33,712 | 33,686 | 32,565 |
Cost of goods sold | -19,389 | -19,260 | -22,663 | -22,997 | -22,793 |
Items affecting comparability - cost of goods sold | -94 | -100 | -9 | -11 | 23 |
Gross profit | 9,194 | 9,047 | 11,040 | 10,678 | 9,795 |
Sales, general and administration | -5,181 | -5,381 | -5,749 | -5,986 | -5,594 |
Items affecting comparability - sales, general and administration | -7 | 161 | -8 | 9 | -224 |
Share of profits of associates and joint ventures | 12 | 16 | 33 | 39 | -2 |
EBITA | 4,018 | 3,843 | 5,316 | 4,740 | 3,975 |
Amortization of acquisition-related intangible assets | -201 | -208 | -201 | -202 | -196 |
Operating profit | 3,817 | 3,635 | 5,115 | 4,538 | 3,779 |
Financial items | -184 | -283 | -319 | -303 | -320 |
Profit before tax | 3,633 | 3,352 | 4,796 | 4,235 | 3,459 |
Income taxes | -1,033 | -844 | -1,186 | -1,189 | -723 |
Net profit for the period | 2,600 | 2,508 | 3,610 | 3,046 | 2,736 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 18 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
CONDENSED INCOME STATEMENT PARENT COMPANY
SEKm | 2009 | 1909 |
Administrative expenses | -557 | -504 |
Other operating income | 28 | 18 |
Operating loss | -529 | -486 |
Financial items | -824 | 3,536 |
Profit before tax | -1,353 | 3,050 |
Income taxes | 274 | 211 |
Profit for the period | -1,079 | 3,261 |
CONDENSED BALANCE SHEET PARENT COMPANY
SEKm | September 30, 2020 | December 31, 2019 |
Intangible assets | 0 | 0 |
Property, plant and equipment | 14 | 16 |
Financial non-current assets | 176,256 | 176,352 |
Total non-current assets | 176,270 | 176,368 |
Total current assets | 603 | 1,794 |
Total assets | 176,873 | 178,162 |
Restricted equity | 2,350 | 2,350 |
Non-restricted equity | 86,863 | 87,942 |
Total equity | 89,213 | 90,292 |
Untaxed reserves | 4 | 4 |
Provisions | 875 | 877 |
Non-current liabilities | 33,310 | 36,386 |
Current liabilities | 53,471 | 50,603 |
Total equity, provisions and liabilities | 176,873 | 178,162 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 19 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
NOTES
1 ACCOUNTING PRINCIPLES
This interim report has been prepared in accordance with IAS 34 and recommendation RFR 1 of the Swedish Financial Reporting Board (RFR), and with regards to the Parent Company, RFR 2.
Effective January 1, 2020, Essity applies the following amended International Financial Reporting Standards (IFRS):
- IFRS 9 Financial Instruments and IFRS 7 Financial Instruments
All other applied accounting principles and calculation methods correspond to those presented in Essity Aktiebolag's (publ) Annual and Sustainability Report for 2019.
IFRS 9 Financial Instruments and IFRS 7 Financial Instruments
Amendments to IFRS 9 and IFRS 7 were adopted on January 15, 2020 as a result of the reference rate reform. The amendments provide temporary exceptions from the application of specific requirements for hedge accounting for hedging relationships that are directly impacted by this reform. The exceptions apply to hedge accounting with the purpose being that companies should not have to discontinue hedging relationships due to uncertainty concerning the reform. The amendments are to be applied as of January 1, 2020 with early application permitted. Essity has elected not to apply these amendments prospectively. At present, the reform primarily impacts Essity's hedging of fair value and EUR LIBOR interest rates. However, these hedges are expected to remain effective in the future. The introduction of the new regulations is therefore not expected to have any material impact on Essity's financial statements.
The assessment is that the above changes will not have any material effect on the Group's or the Parent Company's earnings or financial position.
2 RISKS AND UNCERTAINTIES
Essity's risk exposure and risk management are described on pages 34-39 of the 2019 Annual Report for Essity. No significant changes have taken place that have affected the reported risks.
Risks in conjunction with company acquisitions are analyzed in the due diligence processes that Essity carries out prior to all acquisitions. In cases where acquisitions have been carried out that may affect the assessment of Essity's risk exposure, these are described under the heading "Other events" in the interim and year-end reports.
COVID-19 pandemic
Uncertainty and risks have arisen on account of the COVID-19 pandemic that may affect Essity's sales, earnings and financial position.
Processes for risk management
Essity's Board of Directors determines the Group's strategic direction based on recommendations from the Executive Management Team. Responsibility for the long-term, overall management of strategic risks corresponds to the company's delegation structure, from the Board of Directors to the CEO and from the CEO to the business unit presidents. This means that most operational risks are managed by Essity's business units at the local level, but that they are coordinated when considered necessary. The tools used in this coordination consist primarily of the business units' regular reporting and the annual strategy process, where risks and risk management are a part of the process.
Essity's financial risk management is centralized, as is the Group's internal bank for the Group companies' financial transactions and management of the Group's energy risks. Financial risks are managed in accordance with the Group's finance policy, which is adopted by Essity's Board of Directors and which - together with Essity's energy risk policy - makes up a framework for risk management. Risks are aggregated and monitored on a regular basis to ensure compliance with these guidelines. Essity has also centralized other risk management.
Essity has a staff function for internal audit, which monitors compliance in the organization with the Group's policies.
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 20 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
3 FINANCIAL INSTRUMENTS PER CATEGORY
Distribution by level for measurement at fair value
Financial | |||||||
liabilities | |||||||
Carrying | Measured at | Derivatives | Measured | measured | |||
amount in | fair value | used for | at fair value | at | |||
the balance | through | hedge | through | amortized | Of which fair | ||
SEKm | sheet | profit or loss | accounting | OCI | cost | value by level1 | |
September 30, 2020 | 1 | 2 | |||||
Derivatives | 1,356 | 567 | 789 | - | - | - | 1,356 |
Non-current financial assets | 94 | - | - | 97 | - | 97 | - |
Total assets | 1,450 | 567 | 789 | 97 | 0 | 97 | 1,356 |
Derivatives | 582 | 321 | 261 | - | - | - | 582 |
Financial liabilities | |||||||
Current financial liabilities | 8,105 | 5,294 | - | 2,811 | - | 5,294 | |
Non-current financial liabilities | 40,586 | 11,150 | - | - | 29,436 | - | 11,150 |
Total liabilities | 49,273 | 16,765 | 261 | - | 32,247 | - | 17,026 |
December 31, 2019 | |||||||
Derivatives | 971 | 366 | 605 | - | - | - | 971 |
Non-current financial assets | 96 | - | - | 96 | - | 96 | - |
Total assets | 1,067 | 366 | 605 | 96 | 0 | 96 | 971 |
Derivatives | 991 | 629 | 362 | - | - | - | 991 |
Financial liabilities | |||||||
Current financial liabilities | 8,243 | - | - | - | 8,243 | - | - |
Non-current financial liabilities | 42,984 | 13,167 | - | - | 29,817 | - | 13,167 |
Total liabilities | 52,218 | 13,796 | 362 | - | 38,060 | - | 14,158 |
1No financial instruments have been classified to level 3
The total fair value of the above financial liabilities, excluding lease liabilities, is SEK 46,211m (49,106). The fair value of trade receivables, other current and non-current receivables, cash and cash equivalents, trade payables and other current and non- current liabilities is estimated to be equal to their carrying amount.
No transfers between level 1 and 2 were made during the period.
4 Acquisitions and divestments
On February 27, 2020, it was announced that an agreement had been signed to acquire 75% of the Swedish medical solutions company ABIGO Medical AB. ABIGO Medical AB develops, manufactures and markets products including the Sorbact® technology, which is a clinically established innovation for advanced wound care. The transaction, which was subject to the customary regulatory approvals, was finalized on April 30, 2020.
A preliminary allocation of the purchase consideration is presented below, specifying intangible assets in the form of customer relationships, brands, technology and goodwill. The preliminary allocation may be adjusted. Goodwill is justified since ABIGO Medical AB was already an important partner and supplier to Essity prior to the acquisition, with Essity already using Sorbact® in its wound care products to prevent and treat infections. The company has about 170 employees and net sales in 2019 amounted to SEK 403m.
Since the acquisition, ABIGO Medical AB's recognized net sales amounted to SEK 102m, adjusted EBITDA to SEK 8m and adjusted EBITA to SEK 2m.
If the acquisition had been consolidated as of January 1, 2020, the anticipated sales would have amounted to SEK 211m, adjusted EBITDA to SEK 16m and adjusted EBITA to SEK 7m.
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 21 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
Purchase price allocation, ABIGO Medical AB | Preliminary |
SEKm | |
Intangible assets | 235 |
Non-current assets | 92 |
Current assets | 183 |
Cash and cash equivalents | 47 |
Net debt | -53 |
Provisions and other non-current liabilities | -68 |
Operating liabilities | -69 |
Net identifiable assets and liabilities | 367 |
Goodwill | 532 |
Consideration not transferred, recognized as liability | -225 |
Consideration paid | 674 |
Consideration paid | -674 |
Cash and cash equivalents in acquired operations | 47 |
Effect on the Group's cash and cash equivalents (Consolidated cash flow statement) | -627 |
Acquired net debt excluding cash and cash equivalents | -53 |
Acquisition of operations including net debt taken over (Consolidated operating cash flow statement) | -680 |
On April 1, 2020, Essity acquired 100% of the shares in Novioscan B.V., a Dutch company that develops a wearable ultrasound technology that monitors the bladder and enables continence control. The purchase price for the shares was EUR 4m and the takeover of net debt was EUR 3m. The company has ten employees. Net sales for 2019 and for the second quarter of 2020 were negligible in relation to those of the Essity Group. The purchase price allocation indicated goodwill of SEK 67m.
5 Use of non-IFRS performance measures
Guidelines for Alternative Performance Measures (APMs) for companies with securities listed on a regulated market in the EU have been issued by the European Securities and Markets Authority (ESMA). These guidelines are to be applied for APMs not supported under IFRS.
This interim report refers to a number of performance measures not defined in IFRS. These performance measures are used to help investors, management and other stakeholders analyze the company's operations. These non-IFRS measures may differ from similarly titled measures among other companies. Essity's 2019 Annual Report (pages 64-69) describes the various non- IFRS performance measures that are used as a complement to the financial information presented in accordance with IFRS. Tables are presented below that show how the performance measures have been calculated.
Capital employed
SEKm | 2009 | 1912 |
Total assets | 162,537 | 162,295 |
-Financial assets | -10,043 | -6,988 |
-Non-currentnon-interest bearing liabilities | -6,641 | -7,269 |
-Currentnon-interest bearing liabilities | -34,222 | -34,297 |
Capital employed | 111,631 | 113,741 |
SEKm | 2020:3 | 2020:2 | 2020:1 | 2019:4 | 2019:3 |
Personal Care | 43,268 | 44,150 | 45,684 | 44,268 | 45,630 |
Consumer Tissue | 46,464 | 45,524 | 48,486 | 47,345 | 48,421 |
Professional Hygiene | 22,221 | 23,051 | 24,747 | 22,996 | 24,332 |
Other | -322 | -327 | -354 | -868 | -447 |
Capital employed | 111,631 | 112,398 | 118,563 | 113,741 | 117,936 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 22 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
Working capital
SEKm | 2009 | 1912 |
Inventories | 17,822 | 15,764 |
Trade receivables | 19,031 | 19,864 |
Other current receivables | 2,233 | 2,113 |
Trade payables | -15,089 | -15,802 |
Other current liabilities | -15,972 | -14,998 |
Other | 187 | -159 |
Working capital | 8,212 | 6,782 |
Net debt
SEKm | 2009 | 1912 |
Surplus in funded pension plans | 1,418 | 2,841 |
Non-current financial assets | 715 | 694 |
Current financial assets | 771 | 525 |
Cash and cash equivalents | 7,139 | 2,928 |
Financial assets | 10,043 | 6,988 |
Non-current financial liabilities | 40,627 | 43,079 |
Provisions for pensions | 6,532 | 5,866 |
Current financial liabilities | 8,578 | 8,983 |
Financial liabilities | 55,737 | 57,928 |
Net debt | 45,694 | 50,940 |
EBITDA
SEKm | 2009 | 1909 | 2020:3 | 2019:3 |
Operating profit | 12,567 | 9,811 | 3,817 | 3,779 |
-Amortization of acquisition-related intangible assets | 610 | 576 | 201 | 196 |
-Depreciation/amortization | 4,204 | 4,316 | 1,330 | 1,459 |
-Depreciationright-of-use asset | 700 | 660 | 242 | 224 |
-Impairment | 71 | 4 | 25 | 1 |
-Items affecting comparability - impairment net | 186 | -10 | 116 | -73 |
EBITDA | 18,338 | 15,357 | 5,731 | 5,586 |
-Items affecting comparability excluding depreciation/amortization and impairment | -129 | 721 | -15 | 274 |
Adjusted EBITDA | 18,209 | 16,078 | 5,716 | 5,860 |
EBITA
SEKm | 2009 | 1909 | 2020:3 | 2019:3 |
Operating profit | 12,567 | 9,811 | 3,817 | 3,779 |
-Amortization of acquisition-related intangible assets | 610 | 576 | 201 | 196 |
Operating profit before amortization of acquisition-related intangible assets/EBITA | 13,177 | 10,387 | 4,018 | 3,975 |
EBITA margin (%) | 14.5 | 10.9 | 14.0 | 12.2 |
-Items affecting comparability - cost of goods sold | 203 | 232 | 94 | -23 |
-Items affecting comparability - sales, general and administration | -146 | 479 | 7 | 224 |
Adjusted EBITA | 13,234 | 11,098 | 4,119 | 4,176 |
Adjusted EBITA margin (%) | 14.6 | 11.6 | 14.4 | 12.8 |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 23 |
Essity Aktiebolag (publ) - Third Quarter Report 2020
Operating cash flow
SEKm | 2009 | 1909 | 2020:3 | 2019:3 |
Personal Care | ||||
Operating cash surplus | 6,715 | 6,500 | 2,261 | 2,239 |
Change in working capital | -316 | 240 | 208 | 414 |
Investment in non-current assets, net | -1,026 | -1,148 | -385 | -199 |
Restructuring costs, etc. | 45 | -586 | -32 | -434 |
Operating cash flow before investments in operating assets through leases | 5,418 | 5,006 | 2,052 | 2,020 |
Investment in operating assets through leases | -66 | -154 | -36 | -17 |
Operating cash flow | 5,352 | 4,852 | 2,016 | 2,003 |
Consumer Tissue | ||||
Operating cash surplus | 8,189 | 5,550 | 2,557 | 1,991 |
Change in working capital | -954 | -740 | -1,135 | -397 |
Investment in non-current assets, net | -1,854 | -1,505 | -749 | -422 |
Restructuring costs, etc. | -236 | -148 | -149 | -73 |
Operating cash flow before investments in operating assets through leases | 5,145 | 3,157 | 524 | 1,099 |
Investment in operating assets through leases | -108 | -144 | -9 | -113 |
Operating cash flow | 5,037 | 3,013 | 515 | 986 |
Professional Hygiene | ||||
Operating cash surplus | 4,123 | 4,623 | 1,160 | 1,837 |
Change in working capital | -381 | 177 | 112 | 703 |
Investment in non-current assets, net | -800 | -992 | -310 | -393 |
Restructuring costs, etc. | -487 | -450 | -179 | -155 |
Operating cash flow before investments in operating assets through leases | 2,455 | 3,358 | 783 | 1,992 |
Investment in operating assets through leases | -41 | -43 | 0 | -35 |
Operating cash flow | 2,414 | 3,315 | 783 | 1,957 |
Organic net sales | ||||
SEKm | 2009 | 2020:3 | ||
Personal Care | ||||
Organic net sales | -296 | -186 | ||
Exchange rate effect1 | -1,143 | -978 | ||
Acquisition/Divestments | -41 | 63 | ||
Recognized change | -1,480 | -1,101 | ||
Consumer Tissue | ||||
Organic net sales | 1,313 | 249 | ||
Exchange rate effect1 | -797 | -835 | ||
Acquisition/Divestments | 0 | 0 | ||
Recognized change | 516 | -586 | ||
Professional Hygiene | ||||
Organic net sales | -3,279 | -1,738 | ||
Exchange rate effect1 | -259 | -463 | ||
Acquisition/Divestments | 0 | 0 | ||
Recognized change | -3,538 | -2,201 | ||
Essity | ||||
Organic net sales | -2,252 | -1,673 | ||
Exchange rate effect1 | -2,201 | -2,278 | ||
Acquisition/Divestments | -41 | 63 | ||
Recognized change | -4,494 | -3,888 | ||
1Consists only of currency translation effects |
Essity Aktiebolag (publ), Box 200, SE-101 23 Stockholm, Sweden. www.essity.com. Corp. Reg. No. 556325-5511 | 24 |
Attachments
- Original document
- Permalink
Disclaimer
Essity AB (publ) published this content on 22 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 October 2020 08:39:05 UTC